Skip to main content

Onconetix, Inc.

ONCO
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001782107

No open-market purchases or sales by Onconetix, Inc. insiders were filed in the last 90 days; 6 institutions reported holding it in 13F filings for Q2 2026, worth $73.9K in total; no superinvestor holds it.

Holders of 5% or more of ONCO

Holders whose latest Schedule 13D or 13G filing reports 5% or more of Onconetix, Inc., largest stake first. The change is against the holder's previous filing.

Holders of 5% or more of ONCO
HolderLatest formStakeChangeFirst filedLatest filingFiling
Altos Venture AG13D/A35.80%273.2K shares–Dec 28, 20233 filingsJul 16, 2025SEC
Scablis AG13G7.00%581.9K sharesNewSep 27, 20241 filingSep 27, 2024SEC
Keystone Capital Partners, LLC13G6.10%223.7K sharesNewJul 27, 20261 filingJul 27, 2026SEC

Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.

13D and 13G filings

25 Schedule 13D and 13G filings on Onconetix, Inc., newest first, including old-format filings without a stake.

Schedule 13D and 13G filings on ONCO
Filed (ET)FilerFormStakeChangeEvent dateFiling
Jul 27, 20261:24 PM ETKeystone Capital Partners, LLCand 2 others13G6.10%223.7K sharesNewJul 20, 2026SEC
Jul 16, 20254:03 PM ETAltos Venture AG13D/A35.80%273.2K shares–Jul 14, 2025SEC
Feb 14, 20254:20 PM ETBruhlmann Christian13D/A4.20%611.4K shares–Below 5%Jan 2, 2025SEC
Feb 14, 20254:20 PM ETSchiess Ralph13D/A4.63%673.4K shares–Below 5%Jan 2, 2025SEC
Feb 13, 20252:50 PM ETAmerican Financial Group Inc13G/A0.00%36.0K shares–Below 5%Dec 31, 2024SEC
Feb 7, 20251:28 PM ETZurcher Kantonalbank (Zurich Cantonalbank)13G/A2.50%207.7K shares–Below 5%Dec 24, 2024SEC
Nov 14, 2024Zurcher Kantonalbank (Zurich Cantonalbank)13GOld format–New–SEC
Oct 1, 2024Bruhlmann Christian13DOld format–New–SEC
Oct 1, 2024Schiess Ralph13DOld format–New–SEC
Sep 27, 20243:54 PM ETScablis AG13G7.00%581.9K sharesNewSep 24, 2024SEC
Sep 26, 2024Altos Venture AG13DOld format–––SEC
Sep 26, 2024New Horizon Health Ltd13GOld format–New–SEC
Jun 10, 2024Hernandez Joseph13G/AOld format–––SEC
Jan 26, 2024American Financial Group Inc13G/AOld format–––SEC
Jan 2, 2024Sabby Management, LLC13G/AOld format–––SEC
Dec 28, 2023Altos Venture AG13GOld format–New–SEC
Jun 29, 2023Cincinnati Cornerstone Investors BWV I, LLC13DOld format–––SEC
Apr 13, 2023Cincinnati Cornerstone Investors BWV I, LLC13DOld format–––SEC
Feb 14, 2023Hernandez Joseph13GOld format–New–SEC
Jan 31, 2023American Financial Group Inc13GOld format–New–SEC
Jan 4, 2023Sabby Management, LLC13GOld format–New–SEC
Nov 21, 2022Cincinnati Cornerstone Investors BWV I, LLC13DOld format–––SEC
Aug 29, 2022Cincinnati Cornerstone Investors BWV I, LLC13DOld format–––SEC
Mar 3, 2022Cincytech Fund IV, LLC13DOld format–New–SEC
Mar 3, 2022Cincinnati Cornerstone Investors BWV I, LLC13DOld format–New–SEC

Form 144: proposed insider sales

Notices from officers, directors and other affiliates planning to sell Onconetix, Inc. shares.

No Form 144 notices for Onconetix, Inc. are on file.